ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 155

Polyfunctional Synovial T-Cell Responses and Synovial Invasiveness Repressed By Blockade of Phosphodiesterase 4

Sarah M. Wade1, Mary Canavan1, Trudy McGarry1, Siobhan C. Wade1, Ronan Mullan2, Douglas J. Veale3 and Ursula Fearon1, 1Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 2Department of Rheumatology,, Tallaght Hospital, Dublin, Ireland, 3Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: cytokines, Inflammation, psoriatic arthritis and synovial cells, synovial fluid, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Genetic and functional studies strongly support the role of T-cells in PsA pathophysiology. Effective targeting of T-cells requires a detailed understanding of their phenotypic and functional characteristics at the site of inflammation. This study aims to understand the different components of T-cell responses in the PsA synovium compared to the peripheral blood and investigate the effects of targeting broader pro-inflammatory signalling pathways by interfering with phosphodiesterase 4 (PDE4).

Methods: PsA Synovial tissue cell suspensions, matched synovial fluid mononuclear cells (SFMC) and PsA peripheral blood mononuclear cells (PBMC) were stimulated with PMA and ionomycin in the presence of Brefeldin A and analysed for CD4, CD8, CD161, IL-17A, IFNγ, GM-CSF and TNFα expression by flow cytometry. PsA synovial cell suspensions were cultured in the presence of PDE4 inhibitor, Rolipram (10μM) for 8hr followed by analysis of intracellular cytokines. Polyfunctional cytokine expression was determined by SPICE analysis. The effect of Rolipram treatment on the spontaneous secretion of IL-6, IL-8, MCP-1, IL-1β, RANTES, MMP-1 and MMP-3 was quantified by ELISA. Explants were also embedded in matrigel over a time-course of 1-21 days and synovial outgrowths assessed.

Results: PsA synovial infiltrating T-cells had increased frequencies of CD4 T helper subsets; Th1 (p<0.05), Th17 and exTh17 (p<0.05) compared to the peripheral blood. The production of GM-CSF, IL-17A and IFNγ, but not TNFα, was also higher in the synovial tissue compared to peripheral blood (p<0.05). Strikingly, polyfunctional cells co-expressing GM-CSF, TNF, IL17A and/or IFN-γ were significantly increased in the CD4, CD8, Th1, Th17 and exTh17 compartment of synovial T-cells. Analysis of disease activity revealed that polyfuncitonal cytokine expressing T-cells (p<0.01, r=0.89) and not monofunctional synovial T-cells (p=0.267, r=-0.05) are important to disease progression. Moreover, we revealed that PDE4 blockade can suppress the frequencies of these polyfunctional GM-CSF+TNFα+IL-17A+ and/or IFN-γ+ in CD8, CD4, Th1, Th17 and exTh17 cells (all p<0.05). Finally, using whole tissue synovial explants, which closely reflect the in-vivo inflamed microenvironment of the joint, we demonstrate that PDE4 blockade also inhibits the secretion of pro-inflammatory mediators and synovial invasiveness (p<0.05).

Conclusion: Immunophenotypic analysis of the synovial tissue of PsA patients shows accumulation of Th1, Th17 and exTh17 cells, with a specific increase in polyfunctional cells co-expressing GM-CSF+TNFα+IL-17A+ and/or IFN-γ+, exerting pleiotropic effects and disease progression. Neutralisation of these polyfunctional T-cells and synovial invasiveness by PDE4 may therefore produce optimal inhibition of pro-inflammatory signalling responses in the PsA synovium.


Disclosure: S. M. Wade, None; M. Canavan, None; T. McGarry, None; S. C. Wade, None; R. Mullan, None; D. J. Veale, None; U. Fearon, None.

To cite this abstract in AMA style:

Wade SM, Canavan M, McGarry T, Wade SC, Mullan R, Veale DJ, Fearon U. Polyfunctional Synovial T-Cell Responses and Synovial Invasiveness Repressed By Blockade of Phosphodiesterase 4 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/polyfunctional-synovial-t-cell-responses-and-synovial-invasiveness-repressed-by-blockade-of-phosphodiesterase-4/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polyfunctional-synovial-t-cell-responses-and-synovial-invasiveness-repressed-by-blockade-of-phosphodiesterase-4/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology